Perceptive Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Perceptive Advisors’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-293,362	Closed	-$9.15M	–	111
2022 Q4	$9.15M	Sell	293,362 -394,062	-57%	-$12.9M	0.26%	63
2022 Q3	$13.9M	Sell	687,424 -364,480	-35%	-$6.64M	0.4%	58
2022 Q2	$16.3M	Sell	1,051,904 -463,457	-31%	-$7.97M	0.51%	44
2022 Q1	$29M	Buy	1,515,361 +810,476	+115%	+$14.5M	0.6%	43
2021 Q4	$17.8M	Buy	+704,885	New	+$20.7M	0.28%	73

Other funds holding DICE

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Perceptive Advisors's DICE Position: Q1 2023 in Review

Perceptive Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q1 2023, closing a stake of 293,362 shares — an estimated $9.15M sold.

Perceptive Advisors first reported a position in DICE in Q4 2021 and held it in 5 quarters. The position peaked at $29M in Q1 2022. 115 funds tracked by Wall St. Rank hold DICE as of Q1 2023.

Perceptive Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Perceptive Advisors sold 293,362 DICE Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $9.15M.
Perceptive Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Perceptive Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $29M in Q1 2022.
115 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Perceptive Advisors's 13F filing for Q1 2023, filed 15 May 2023.